{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:51:00Z","timestamp":1791305460295,"version":"4.3.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11095-026-04154-9","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:32:05Z","timestamp":1784050325000},"page":"3299-3315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Raman Spectroscopy for Characterizing Monoclonal Antibody Reduction: A Process Analytical Technology Approach for Antibody\u2013Drug Conjugation Process Development"],"prefix":"10.1007","volume":"43","author":[{"given":"David","family":"Pople","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Kozyryev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumit","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Appiah-Amponsah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0822-2965","authenticated-orcid":false,"given":"Hanzhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"4154_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrc2394","volume":"8","author":"K Strebhardt","year":"2008","unstructured":"Strebhardt K, Ullrich A. Paul Ehrlich\u2019s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8:473\u201380. https:\/\/doi.org\/10.1038\/nrc2394.","journal-title":"Nat Rev Cancer"},{"key":"4154_CR2","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/d41573-024-00064-w","volume":"23","author":"P Flynn","year":"2024","unstructured":"Flynn P, Suryaprakash S, Grossman D, Panier V, Wu J. The antibody\u2013drug conjugate landscape. Nat Rev Drug Discov. 2024;23:577\u20138. https:\/\/doi.org\/10.1038\/d41573-024-00064-w.","journal-title":"Nat Rev Drug Discov"},{"key":"4154_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-025-01704-3","volume":"18","author":"R Wang","year":"2025","unstructured":"Wang R, Hu B, Pan Z, Mo C, Zhao X, Liu G, et al. Antibody\u2013drug conjugates (ADCs): current and future biopharmaceuticals. J Hematol Oncol. 2025;18:51. https:\/\/doi.org\/10.1186\/s13045-025-01704-3.","journal-title":"J Hematol Oncol"},{"key":"4154_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","volume":"21","author":"K Tsuchikama","year":"2024","unstructured":"Tsuchikama K, Anami Y, Ha SYY, Yamazaki CM. Exploring the next generation of antibody\u2013drug conjugates. Nat Rev Clin Oncol. 2024;21:203\u201323. https:\/\/doi.org\/10.1038\/s41571-023-00850-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"4154_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12885-025-13726-8","volume":"25","author":"H Wei","year":"2025","unstructured":"Wei H, Zhang Y, Lu Y, Zou Y, Zhou L, Qin X, et al. Is ADC a rising star in solid tumor? An umbrella review of systematic reviews and meta-analyses. BMC Cancer. 2025;25:380. https:\/\/doi.org\/10.1186\/s12885-025-13726-8.","journal-title":"BMC Cancer"},{"key":"4154_CR6","doi-asserted-by":"publisher","first-page":"D1097","DOI":"10.1093\/nar\/gkad831","volume":"52","author":"L Shen","year":"2024","unstructured":"Shen L, Sun X, Chen Z, Guo Y, Shen Z, Song Y, et al. ADCdb: the database of antibody\u2013drug conjugates. Nucleic Acids Res. 2024;52:D1097\u2013109. https:\/\/doi.org\/10.1093\/nar\/gkad831.","journal-title":"Nucleic Acids Res"},{"key":"4154_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/abt\/tbaf010","volume":"8","author":"Q Fan","year":"2025","unstructured":"Fan Q, Chen H, Wei G, Wei D, Wang Z, Zhang L, et al. A review of conjugation technologies for antibody drug conjugates. Antib Ther. 2025;8:157\u201370. https:\/\/doi.org\/10.1093\/abt\/tbaf010.","journal-title":"Antib Ther"},{"key":"4154_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11095-023-03649-z","volume":"41","author":"M Li","year":"2024","unstructured":"Li M, Zhao X, Yu C, Wang L. Antibody-drug conjugate overview: a state-of-the-art manufacturing process and control strategy. Pharm Res. 2024;41:419\u201340. https:\/\/doi.org\/10.1007\/s11095-023-03649-z.","journal-title":"Pharm Res"},{"key":"4154_CR9","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1007\/s11095-014-1584-z","volume":"32","author":"AV Kamath","year":"2015","unstructured":"Kamath AV, Iyer S. Preclinical pharmacokinetic considerations for the development of antibody drug conjugates. Pharm Res. 2015;32:3470\u20139. https:\/\/doi.org\/10.1007\/s11095-014-1584-z.","journal-title":"Pharm Res"},{"key":"4154_CR10","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1021\/acs.molpharmaceut.5b00432","volume":"12","author":"CR Behrens","year":"2015","unstructured":"Behrens CR, Ha EH, Chinn LL, Bowers S, Probst G, Fitch-Bruhns M, et al. Antibody\u2013drug conjugates (ADCs) derived from interchain cysteine cross-linking demonstrate improved homogeneity and other pharmacological properties over conventional heterogeneous ADCs. Mol Pharm. 2015;12:3986\u201398. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00432.","journal-title":"Mol Pharm"},{"key":"4154_CR11","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00253-022-11778-5","volume":"106","author":"Y Song","year":"2022","unstructured":"Song Y, Cai H, Tan Z, Mussa N, Li Z-J. Mechanistic insights into inter-chain disulfide bond reduction of IgG1 and IgG4 antibodies. Appl Microbiol Biotechnol. 2022;106:1057\u201366. https:\/\/doi.org\/10.1007\/s00253-022-11778-5.","journal-title":"Appl Microbiol Biotechnol"},{"key":"4154_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/bit.28899","volume":"122","author":"JT Weggen","year":"2025","unstructured":"Weggen JT, Gonz\u00e1lez P, Hui K, Bean R, Wendeler M, Hubbuch J. Kinetic Modeling of the Antibody Disulfide Bond Reduction Reaction With Integrated Prediction of the Drug Load Profile for Cysteine-Conjugated ADCs. Biotechnol Bioeng. 2025;122:579\u201393. https:\/\/doi.org\/10.1002\/bit.28899.","journal-title":"Biotechnol Bioeng"},{"key":"4154_CR13","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1021\/bc050201y","volume":"16","author":"MMC Sun","year":"2005","unstructured":"Sun MMC, Beam KS, Cerveny CG, Hamblett KJ, Blackmore RS, Torgov MY, et al. Reduction\u2212Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides. Bioconjug Chem. 2005;16:1282\u201390. https:\/\/doi.org\/10.1021\/bc050201y.","journal-title":"Bioconjug Chem"},{"key":"4154_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4161\/mabs.26773","volume":"6","author":"E Wagner-Rousset","year":"2014","unstructured":"Wagner-Rousset E, Janin-Bussat M-C, Colas O, Excoffier M, Ayoub D, Haeuw J-F, et al. Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion. MAbs. 2014;6:173\u201384. https:\/\/doi.org\/10.4161\/mabs.26773.","journal-title":"MAbs"},{"key":"4154_CR15","doi-asserted-by":"publisher","first-page":"464721","DOI":"10.1016\/j.chroma.2024.464721","volume":"1718","author":"J Chen","year":"2024","unstructured":"Chen J, Wang J, Hess R, Wang G, Studts J, Franzreb M. Application of Raman spectroscopy during pharmaceutical process development for determination of critical quality attributes in Protein A chromatography. J Chromatogr A. 2024;1718:464721. https:\/\/doi.org\/10.1016\/j.chroma.2024.464721.","journal-title":"J Chromatogr A"},{"key":"4154_CR16","doi-asserted-by":"publisher","first-page":"e70013","DOI":"10.1002\/ansa.70013","volume":"6","author":"P Sathiyapriyan","year":"2025","unstructured":"Sathiyapriyan P, Mukherjee S, Vogel T, Essen L-O, Boerema D, Vey M, et al. Current PAT Landscape in the Downstream Processing of Biopharmaceuticals. Anal Sci Adv. 2025;6:e70013. https:\/\/doi.org\/10.1002\/ansa.70013.","journal-title":"Anal Sci Adv"},{"key":"4154_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.aca.2006.04.086","volume":"571","author":"P Roychoudhury","year":"2006","unstructured":"Roychoudhury P, Harvey LM, McNeil B. The potential of mid infrared spectroscopy (MIRS) for real time bioprocess monitoring. Anal Chim Acta. 2006;571:159\u201366. https:\/\/doi.org\/10.1016\/j.aca.2006.04.086.","journal-title":"Anal Chim Acta"},{"key":"4154_CR18","doi-asserted-by":"publisher","first-page":"120456","DOI":"10.1016\/j.ijpharm.2021.120456","volume":"600","author":"G Thakur","year":"2021","unstructured":"Thakur G, Hebbi V, Rathore AS. Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations. Int J Pharm. 2021;600:120456. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120456.","journal-title":"Int J Pharm"},{"key":"4154_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nprot.2015.024","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang H, Yang S, Kong J, Dong A, Yu S. Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy. Nat Protoc. 2015;10:382\u201396. https:\/\/doi.org\/10.1038\/nprot.2015.024.","journal-title":"Nat Protoc"},{"key":"4154_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0308-8146(02)00583-6","volume":"82","author":"H B\u00fcning-Pfaue","year":"2003","unstructured":"B\u00fcning-Pfaue H. Analysis of water in food by near infrared spectroscopy. Food Chem. 2003;82:107\u201315. https:\/\/doi.org\/10.1016\/S0308-8146(02)00583-6.","journal-title":"Food Chem"},{"key":"4154_CR21","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1002\/pro.5560041120","volume":"4","author":"CN Pace","year":"1995","unstructured":"Pace CN, Vajdos F, Fee L, Grimsley G, Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 1995;4:2411\u201323. https:\/\/doi.org\/10.1002\/pro.5560041120.","journal-title":"Protein Sci"},{"key":"4154_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0076-6879(90)82008-p","volume":"182","author":"CM Stoscheck","year":"1990","unstructured":"Stoscheck CM. Quantitation of protein. Methods Enzymol. 1990;182:50\u201368. https:\/\/doi.org\/10.1016\/0076-6879(90)82008-p.","journal-title":"Methods Enzymol"},{"key":"4154_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nprot.2016.036","volume":"11","author":"HJ Butler","year":"2016","unstructured":"Butler HJ, Ashton L, Bird B, Cinque G, Curtis K, Dorney J, et al. Using Raman spectroscopy to characterize biological materials. Nat Protoc. 2016;11:664\u201387. https:\/\/doi.org\/10.1038\/nprot.2016.036.","journal-title":"Nat Protoc"},{"key":"4154_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/elsc.201700084","volume":"18","author":"H Bhatia","year":"2018","unstructured":"Bhatia H, Mehdizadeh H, Drapeau D, Yoon S. In-line monitoring of amino acids in mammalian cell cultures using raman spectroscopy and multivariate chemometrics models. Eng Life Sci. 2018;18:55\u201361. https:\/\/doi.org\/10.1002\/elsc.201700084.","journal-title":"Eng Life Sci"},{"key":"4154_CR25","doi-asserted-by":"publisher","first-page":"102937","DOI":"10.1016\/j.copbio.2023.102937","volume":"81","author":"J-C Matuszczyk","year":"2023","unstructured":"Matuszczyk J-C, Zijlstra G, Ede D, Ghaffari N, Yuh J, Brivio V. Raman spectroscopy provides valuable process insights for cell-derived and cellular products. Curr Opin Biotechnol. 2023;81:102937. https:\/\/doi.org\/10.1016\/j.copbio.2023.102937.","journal-title":"Curr Opin Biotechnol"},{"key":"4154_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00216-021-03727-4","volume":"414","author":"KA Esmonde-White","year":"2022","unstructured":"Esmonde-White KA, Cuellar M, Lewis IR. The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing. Anal Bioanal Chem. 2022;414:969\u201391. https:\/\/doi.org\/10.1007\/s00216-021-03727-4.","journal-title":"Anal Bioanal Chem"},{"key":"4154_CR27","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1021\/acs.analchem.3c05628","volume":"96","author":"H Feng","year":"2024","unstructured":"Feng H, Dunn ZD, Kargupta R, Desai J, Phuangthong C, Venkata T, et al. Pioneering Just-in-Time (JIT) Strategy for Accelerating Raman Method Development and Implementation for Biologic Continuous Manufacturing. Anal Chem. 2024;96:3168\u201376. https:\/\/doi.org\/10.1021\/acs.analchem.3c05628.","journal-title":"Anal Chem"},{"key":"4154_CR28","doi-asserted-by":"publisher","first-page":"e2847","DOI":"10.1002\/btpr.2847","volume":"35","author":"F Feidl","year":"2019","unstructured":"Feidl F, Garbellini S, Vogg S, Sokolov M, Souquet J, Broly H, et al. A new flow cell and chemometric protocol for implementing in-line Raman spectroscopy in chromatography. Biotechnol Prog. 2019;35:e2847. https:\/\/doi.org\/10.1002\/btpr.2847.","journal-title":"Biotechnol Prog"},{"key":"4154_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ijbiomac.2021.02.214","volume":"179","author":"N Nitika","year":"2021","unstructured":"Nitika N, Chhabra H, Rathore AS. Raman spectroscopy for in situ, real time monitoring of protein aggregation in lyophilized biotherapeutic products. Int J Biol Macromol. 2021;179:309\u201313. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.02.214.","journal-title":"Int J Biol Macromol"},{"key":"4154_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ab.2018.06.003","volume":"555","author":"C Qiu","year":"2018","unstructured":"Qiu C, Arzhantsev S. Secondary structure assessment of formulated bevacizumab in the presence of SDS by deep ultraviolet resonance Raman (DUVRR) spectroscopy. Anal Biochem. 2018;555:26\u201332. https:\/\/doi.org\/10.1016\/j.ab.2018.06.003.","journal-title":"Anal Biochem"},{"key":"4154_CR31","doi-asserted-by":"publisher","first-page":"7880","DOI":"10.1021\/acs.analchem.5b01606","volume":"87","author":"J Bueno","year":"2015","unstructured":"Bueno J, Long D, Kauffman JF, Arzhantsev S. Deep-Ultraviolet Resonance Raman (DUVRR) Spectroscopy of Therapeutic Monoclonal Antibodies Subjected to Thermal Stress. Anal Chem. 2015;87:7880\u20136. https:\/\/doi.org\/10.1021\/acs.analchem.5b01606.","journal-title":"Anal Chem"},{"key":"4154_CR32","doi-asserted-by":"publisher","first-page":"10381","DOI":"10.1021\/acs.analchem.0c00627","volume":"92","author":"BS McAvan","year":"2020","unstructured":"McAvan BS, Bowsher LA, Powell T, O\u2019Hara JF, Spitali M, Goodacre R, et al. Raman Spectroscopy to Monitor Post-Translational Modifications and Degradation in Monoclonal Antibody Therapeutics. Anal Chem. 2020;92:10381\u20139. https:\/\/doi.org\/10.1021\/acs.analchem.0c00627.","journal-title":"Anal Chem"},{"key":"4154_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/138920109788488950","volume":"10","author":"CH Li","year":"2009","unstructured":"Li CH, Li T. Application of Vibrational Spectroscopy to the Structural Characterization of Monoclonal Antibody and its Aggregate. Curr Pharm Biotechnol. 2009;10:391\u20139. https:\/\/doi.org\/10.2174\/138920109788488950.","journal-title":"Curr Pharm Biotechnol"},{"key":"4154_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2472555219875102","volume":"25","author":"WA Hassanain","year":"2020","unstructured":"Hassanain WA, Izake EL. Toward Label-Free SERS Detection of Proteins through Their Disulfide Bond Structure. SLAS Discov. 2020;25:87\u201394. https:\/\/doi.org\/10.1177\/2472555219875102.","journal-title":"SLAS Discov"},{"key":"4154_CR35","doi-asserted-by":"publisher","first-page":"116530","DOI":"10.1016\/j.jpba.2024.116530","volume":"252","author":"Z Wang","year":"2025","unstructured":"Wang Z, Hsieh A, Rose P, Zhou G, Battle S, Raymond K, et al. Raman spectroscopy for monitoring free sulfhydryl formation during monoclonal antibody manufacturing. J Pharm Biomed Anal. 2025;252:116530. https:\/\/doi.org\/10.1016\/j.jpba.2024.116530.","journal-title":"J Pharm Biomed Anal"},{"key":"4154_CR36","doi-asserted-by":"publisher","first-page":"119712","DOI":"10.1016\/j.saa.2021.119712","volume":"258","author":"N Kuhar","year":"2021","unstructured":"Kuhar N, Sil S, Umapathy S. Potential of Raman spectroscopic techniques to study proteins. Spectrochim Acta A Mol Biomol Spectrosc. 2021;258:119712. https:\/\/doi.org\/10.1016\/j.saa.2021.119712.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"4154_CR37","doi-asserted-by":"publisher","DOI":"10.1201\/b16936","volume-title":"Infrared and Raman spectroscopy of biological materials","author":"E Carter","year":"2000","unstructured":"Carter E, Edwards HGM. Infrared and Raman spectroscopy of biological materials. Boca Raton: CRC Press; 2000. https:\/\/doi.org\/10.1201\/b16936."},{"key":"4154_CR38","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.xphs.2018.12.027","volume":"108","author":"GV Barnett","year":"2019","unstructured":"Barnett GV, Balakrishnan G, Chennamsetty N, Hoffman L, Bongers J, Tao L, et al. Probing the Tryptophan Environment in Therapeutic Proteins: Implications for Higher Order Structure on Tryptophan Oxidation. J Pharm Sci. 2019;108:1944\u201352. https:\/\/doi.org\/10.1016\/j.xphs.2018.12.027.","journal-title":"J Pharm Sci"},{"key":"4154_CR39","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1002\/slct.202001822","volume":"5","author":"Y Matsuda","year":"2020","unstructured":"Matsuda Y, Tawfiq Z, Leung M, Mendelsohn BA. Insight into Temperature Dependency and Design of Experiments towards Process Development for Cysteine-Based Antibody-Drug Conjugates. ChemistrySelect. 2020;5:8435\u20139. https:\/\/doi.org\/10.1002\/slct.202001822.","journal-title":"ChemistrySelect"},{"key":"4154_CR40","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.1021\/acs.analchem.5b01996","volume":"87","author":"E Trabjerg","year":"2015","unstructured":"Trabjerg E, Jakobsen RU, Mysling S, Christensen S, J\u00f8rgensen TJD, Rand KD. Conformational Analysis of Large and Highly Disulfide-Stabilized Proteins by Integrating Online Electrochemical Reduction into an Optimized H\/D Exchange Mass Spectrometry Workflow. Anal Chem. 2015;87:8880\u20138. https:\/\/doi.org\/10.1021\/acs.analchem.5b01996.","journal-title":"Anal Chem"},{"key":"4154_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1006\/abio.1994.1290","volume":"220","author":"JC Han","year":"1994","unstructured":"Han JC, Han GY. A Procedure for Quantitative Determination of Tris(2-Carboxyethyl)phosphine, an Odorless Reducing Agent More Stable and Effective Than Dithiothreitol. Anal Biochem. 1994;220:5\u201310. https:\/\/doi.org\/10.1006\/abio.1994.1290.","journal-title":"Anal Biochem"},{"key":"4154_CR42","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1021\/jo00008a014","volume":"56","author":"JA Burns","year":"1991","unstructured":"Burns JA, Butler JC, Moran J, Whitesides GM. Selective reduction of disulfides by tris(2-carboxyethyl)phosphine. J Org Chem. 1991;56:2648\u201350. https:\/\/doi.org\/10.1021\/jo00008a014.","journal-title":"J Org Chem"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04154-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04154-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04154-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:54:40Z","timestamp":1791302080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04154-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4154"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04154-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}